Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

Name Upside % Analysts
bullish %
XNCR icon
26
Xencor
XNCR
$574M
179%
upside
3 price targets
0
SLDB icon
27
Solid Biosciences
SLDB
$438M
177%
upside
6 price targets
0
ZVRA icon
28
Zevra Therapeutics
ZVRA
$522M
168%
upside
3 price targets
0
PROK icon
29
ProKidney
PROK
$337M
165%
upside
4 price targets
0
ARCT icon
30
Arcturus Therapeutics
ARCT
$470M
165%
upside
4 price targets
0
EOLS icon
31
Evolus
EOLS
$486M
162%
upside
3 price targets
0
EVTL icon
32
Vertical Aerospace
EVTL
$505M
157%
upside
4 price targets
0
MBX
33
MBX Biosciences, Inc. Common Stock
MBX
$479M
147%
upside
3 price targets
0
SNDX icon
34
Syndax Pharmaceuticals
SNDX
$1.41B
145%
upside
4 price targets
0
RCKT icon
35
Rocket Pharmaceuticals
RCKT
$361M
144%
upside
6 price targets
0
HIVE
36
HIVE Digital Technologies
HIVE
$675M
131%
upside
5 price targets
0
IMNM icon
37
Immunome
IMNM
$862M
128%
upside
3 price targets
0
ELVN icon
38
Enliven Therapeutics
ELVN
$1.21B
125%
upside
3 price targets
0
ANAB icon
39
AnaptysBio
ANAB
$563M
125%
upside
4 price targets
0
EYPT icon
40
EyePoint Pharmaceuticals
EYPT
$800M
125%
upside
3 price targets
0
DYN icon
41
Dyne Therapeutics
DYN
$1.96B
125%
upside
10 price targets
0
GETY icon
42
Getty Images
GETY
$759M
124%
upside
3 price targets
0
DMAC icon
43
DiaMedica Therapeutics
DMAC
$303M
116%
upside
3 price targets
0
MLYS icon
44
Mineralys Therapeutics
MLYS
$1.01B
115%
upside
3 price targets
0
CLDX icon
45
Celldex Therapeutics
CLDX
$1.49B
115%
upside
4 price targets
0
PRAX icon
46
Praxis Precision Medicines
PRAX
$968M
114%
upside
4 price targets
0
TVRD
47
Tvardi Therapeutics, Inc. Common Stock
TVRD
$284M
114%
upside
3 price targets
0
NUVB icon
48
Nuvation Bio
NUVB
$999M
102%
upside
3 price targets
0
AVBP icon
49
ArriVent BioPharma
AVBP
$779M
100%
upside
6 price targets
0
TVTX icon
50
Travere Therapeutics
TVTX
$1.58B
97%
upside
5 price targets
0